Department of Palliative, Rehabilitation, and Integrative Medicine and The University of Texas MD Anderson Cancer, Houston, Texas, USA.
Department of Supportive and Palliative Care, Baylor University Medical Center, Dallas, Texas, USA.
J Palliat Med. 2023 Feb;26(2):248-252. doi: 10.1089/jpm.2022.0293. Epub 2022 Dec 7.
Data on health care providers' (HCPs') perceptions about patients with cancer pain and nonmedical opioid use (NMOU) are lacking. We examined the perceptions and attitudes of HCPs and assessed the usefulness of an interdisciplinary opioid stewardship program (OSP) while caring for these patients. An anonymous cross-sectional survey was conducted among the supportive care HCPs between September and November 2021. Of 85 HCPs, 64 responded (75%) to the survey. Participants perceived that NMOU is underdiagnosed (42/64; 67%), and caring for such patients is difficult (58/64, 91%) and time consuming (54/64, 87%). A majority (50/51, 98%) were aware of the OSP, and (48/51; 94%) found it helpful. HCPs reported that NMOU is underdiagnosed and is challenging to manage. They endorsed the utility of an OSP in managing patients with concurrent cancer pain and NMOU. Future research should identify ways to standardize care and integrate OSP in routine supportive oncology practice.
关于医疗保健提供者（HCPs）对癌症疼痛和非医疗阿片类药物使用（NMOU）患者的看法的数据尚缺乏。我们研究了 HCPs 的看法和态度，并评估了在照顾这些患者时，跨学科阿片类药物管理计划（OSP）的有用性。 2021 年 9 月至 11 月期间，对支持性护理 HCPs 进行了一项匿名横断面调查。 在 85 名 HCP 中，有 64 名（75%）对调查做出了回应。参与者认为 NMOU 诊断不足（42/64；67%），照顾此类患者困难（58/64，91%）且耗时（54/64，87%）。大多数人（50/51，98%）知道 OSP，并且（48/51；94%）认为它有帮助。 HCPs 报告 NMOU 诊断不足且难以管理。他们认可 OSP 在管理同时患有癌症疼痛和 NMOU 的患者方面的效用。未来的研究应确定标准化护理和将 OSP 纳入常规支持性肿瘤学实践的方法。
